Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Implied Volatility Surging for Synergy Pharmaceuticals (SGYP) Stock Options

Investors need to pay close attention to Synergy Pharmaceuticals (SGYP) stock based on the movements in the options market lately.

SGYP : 1.68 (+5.00%)
Look for Shares of Synergy Pharmace to Potentially Rebound after Yesterday's 1.53% Sell Off

Synergy Pharmace (NASDAQ:SGYP) traded in a range yesterday that spanned from a low of $1.43 to a high of $1.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $1.50...

SGYP : 1.68 (+5.00%)
Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update

--Synergy lowers 2018 adjusted operating expense (non-GAAP) guidance

SGYP : 1.68 (+5.00%)
Synergy Pharmaceuticals to Report First Quarter 2018 Financial Results and Host Conference Call and Webcast

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced it intends...

SGYP : 1.68 (+5.00%)
Options Traders Expect Huge Moves in Synergy Pharmaceuticals (SGYP) Stock

Investors in Synergy Pharmaceuticals (SGYP) need to pay close attention to the stock based on moves in the options market lately.

SGYP : 1.68 (+5.00%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Reminds Investors With Losses In Excess of $50,000 to Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 10, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.68 (+5.00%)
Glancy Prongay & Murray LLP Reminds Investors of the April 10, 2018 Deadline in the Class Action Lawsuit Against Synergy Pharmaceuticals Inc. (SGYP)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the April 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased...

SGYP : 1.68 (+5.00%)
SGYP DEADLINE TODAY: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018

NEW YORK, NY / ACCESSWIRE / April 10, 2018 / The Law Offices of Vincent Wong announce that class action lawsuits have been commenced in the United States District Court for the Eastern District of New...

SGYP : 1.68 (+5.00%)
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Synergy Pharmaceuticals Inc. (SGYP) & Lead Plaintiff Deadline: April 10, 2018

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ:SGYP) and...

SGYP : 1.68 (+5.00%)
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Synergy Pharmaceuticals Inc. Investors (SGYP)

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired Synergy Pharmaceuticals Inc. ("Synergy"...

SGYP : 1.68 (+5.00%)
EQUITY NOTICE: Rosen Law Firm Reminds Synergy Pharmaceuticals Inc. Investors of Important April 10, 2018 Deadline in Class Action - SGYP

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through November 14, 2017, inclusive...

SGYP : 1.68 (+5.00%)
FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 9, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.68 (+5.00%)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synergy Pharmaceuticals, Inc. (SGYP) and Encourages Investors to Contact the Firm Before April 10th

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf...

SGYP : 1.68 (+5.00%)
DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Synergy Pharmaceuticals Inc. of Class Actions and a Lead Plaintiff Deadline of April 10, 2018 - SGYP

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

SGYP : 1.68 (+5.00%)
DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 7, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.68 (+5.00%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - SGYP

NEW YORK, NY / ACCESSWIRE / April 6, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. ("Synergy" or the "Company") (NASDAQ: SGYP) and certain...

SGYP : 1.68 (+5.00%)
Watch for Synergy Pharmace to Potentially Pullback After Gaining 1.60% Yesterday

Synergy Pharmace (NASDAQ:SGYP) traded in a range yesterday that spanned from a low of $1.84 to a high of $1.95. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

SGYP : 1.68 (+5.00%)
APRIL 10 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / April 6, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals Inc. ("Synergy" or "the Company")...

SGYP : 1.68 (+5.00%)
Synergy Pharmaceuticals Inc. Reminder: Important April 10, 2018 Lead Plaintiff Deadline in Class Action- SGYP

NEW YORK, NY / ACCESWIRE / April 5, 2018 / Pawar Law Group reminds shareholders who purchased shares of Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through November 14, 2017, inclusive (the...

SGYP : 1.68 (+5.00%)
SGYP UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of Class Actions Involving Synergy Pharmaceuticals Inc. and a Lead Plaintiff Deadline of April 10, 2018

NEW YORK, NY / ACCESSWIRE / April 5, 2018 / The Law Offices of Vincent Wong announce that class action lawsuits have been commenced in the United States District Court for the Eastern District of New York...

SGYP : 1.68 (+5.00%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar